Obesity Trial, Recruiting NCT07395973 Sponsor: Maastricht University Medical Center Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07395973
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 60 and 80 years old
  • People with a body mass index (BMI) between 25 and 35 (a measure of body weight relative to height — confirm with trial site if unsure)
  • People who do less than 2 hours of organised physical activity per week and have been living this way for at least the past 3 months
  • People whose eating habits have been consistent, with no weight change of more than 5 kg in the past 3 months
  • People considered healthy based on a medical questionnaire reviewed by a doctor
  • People who regularly sleep 7 to 9 hours per night

Who may not be able to join:

  • People who have Type 2 diabetes
  • People with active heart failure or severe kidney or liver problems
  • People with high blood pressure that is not well controlled by treatment
  • People who drink more than 3 alcoholic drinks per day (men) or more than 2 per day (women)
  • People whose weight has changed by more than 5 kg in the last 3 months, or who are currently trying to lose weight
  • People who follow an intermittent fasting diet
  • People who have taken part in another clinical trial involving an investigational product within the last 3 months
  • People with significant food allergies or intolerances that would interfere with study meals or products
  • People who do not wish to be told about any unexpected medical findings discovered during the study
  • People who have donated blood during the study period or within 2 months before it begins
  • People whose sleep-wake patterns are significantly disrupted, including those who score as an extreme early riser or extreme night owl on a standard sleep questionnaire, those with heavily irregular sleep schedules, those who have worked night shifts in the last 3 months, or those who have travelled across more than one time zone in the last 3 months
  • People with a high daily caffeine intake of more than 400 mg (roughly more than 4 cups of coffee or energy drinks per day)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joris Hoeks, Dr., Maastricht University

Phone: 0031 88 3887793

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
25 November 2025
Est. completion
31 October 2027

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Delta respiratory exchange ratio (from 23:00 till 04:00)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov